Role of toll like receptors (TLRs)in Gd contrast agent induced skin fibrosis
Toll样受体(TLRs)在Gd造影剂诱导的皮肤纤维化中的作用
基本信息
- 批准号:8549103
- 负责人:
- 金额:$ 19.88万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-09-24 至 2014-12-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdenineAffectAnimal ModelCell Surface ReceptorsCellsChronic Kidney FailureChronic Kidney InsufficiencyContrast MediaCytokine ActivationDepositionDermalDevelopmentDietDiseaseDoseEventExposure toFibroblastsFibrosisGadoliniumGene ExpressionHistologicHumanHuman CharacteristicsImplantInfiltrationInflammationInfusion proceduresInjection of therapeutic agentInvestigationKidneyKidney DiseasesKidney FailureLesionLigandsMagnetic ResonanceModelingMolecularMolecular TargetMusNatural ImmunityNephrectomyOmniscanPathogenesisPathway interactionsPatientsPatternPeripheral Blood Mononuclear CellProcessProductionPublishingPulmonary FibrosisPumpReporter GenesReportingRodentRoleScanningSclerodermaSignal PathwaySkinSystemSystemic SclerodermaTLR4 geneTLR7 geneTailTestingTissuesToll-Like Receptor PathwayToll-like receptorsVeinsbasechemokinecytokineeffective therapygadodiamidegadolinium oxideimplantationinterestmacrophagemonocytenovelresearch studyresponseskin lesiontherapeutic target
项目摘要
DESCRIPTION (provided by applicant): Nephrogenic Systemic Fibrosis (NSF) is a rare condition occurring in a small subset of patients with renal insufficiency following exposure to Gadolinium based contrast agents (GdBCA). This disorder is characterized by severe dermal and systemic fibrosis with the presence of large numbers of activated macrophages, fibrocytes and fibroblasts in affected tissues. Several published studies have reported the development of skin lesions in sub-total nephrectomized rodents injected with high doses of GdBCA, however, these lesions do not demonstrate many of the histopathological characteristics of human NSF lesions. To overcome this flaw, we propose to develop a more realistic and informative animal model of NSF by utilizing mice with adenine-induced renal failure that have either been injected intravenously with high dose GdBCA or that have been exposed to GdBCA via subdermally implanted osmotic pumps or by intratracheal instillation. Given the intense interest in the role of
macrophages and, in particular, of the Toll-like receptor (TLR) pathway in the development of fibrosis, we will perform extensive mechanistic studies to examine the role of macrophages and TLRs in the development of GdBCA induced fibrosis in this new model. The hypotheses to be tested will be: 1) GdBCA exposure induces NSF-like fibrotic lesions, 2) activated macrophages are required to induce these lesions; and 3) the induction requires engagement of TLR4 and/or TLR7. To test these hypotheses, the following specific aims are proposed: SPECIFIC AIM 1: Induce fibrosis by GdBCA administration in C57BL/6J mice with adenine induced renal failure. SPECIFIC AIM 2: Investigate the role of macrophages and of TLR4 and TLR7 in the development of fibrosis in mice with adenine induced renal disease. The studies proposed here will provide valuable information regarding the initial molecular events that couple exogenous or environmental etiologic factors with inflammation and fibrosis focusing on the participation of the
innate immunity system and TLR responses in these processes. Furthermore, these studies will provide important clues regarding the pathogenesis of idiopathic systemic fibrotic disorders such as SSc and may allow the identification of novel potential therapeutic targets for these diseases.
描述(由申请人提供):肾源性系统性纤维化(NSF)是一种罕见疾病,发生在一小部分肾功能不全患者暴露于钆基造影剂(GdBCA)后。这种疾病的特征是严重的真皮和全身纤维化,受影响的组织中存在大量活化的巨噬细胞、纤维细胞和成纤维细胞。几项已发表的研究报道了注射高剂量 GdBCA 的次全肾切除啮齿动物出现皮肤病变,然而,这些病变并未表现出人类 NSF 病变的许多组织病理学特征。为了克服这一缺陷,我们建议利用腺嘌呤诱导肾衰竭的小鼠开发一种更真实、信息更丰富的 NSF 动物模型,这些小鼠要么静脉注射高剂量 GdBCA,要么通过皮下植入渗透泵或通过气管内滴注暴露于 GdBCA。鉴于人们对这个角色的浓厚兴趣
为了研究巨噬细胞,特别是 Toll 样受体 (TLR) 通路在纤维化发展中的作用,我们将进行广泛的机制研究,以检验巨噬细胞和 TLR 在这个新模型中 GdBCA 诱导的纤维化发展中的作用。 要测试的假设是:1) GdBCA 暴露诱发 NSF 样纤维化病变,2) 需要激活的巨噬细胞来诱发这些病变; 3)诱导需要TLR4和/或TLR7的参与。为了检验这些假设,提出以下具体目标: 具体目标 1:通过在患有腺嘌呤诱导的肾衰竭的 C57BL/6J 小鼠中施用 GdBCA 来诱导纤维化。具体目标 2:研究巨噬细胞以及 TLR4 和 TLR7 在腺嘌呤诱导的肾病小鼠纤维化发展中的作用。这里提出的研究将提供有关将外源或环境病因与炎症和纤维化耦合的初始分子事件的有价值的信息,重点关注炎症和纤维化的参与
先天免疫系统和 TLR 在这些过程中的反应。此外,这些研究将为特发性系统性纤维化疾病(如 SSc)的发病机制提供重要线索,并可能为这些疾病确定新的潜在治疗靶点。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The significance of macrophage polarization subtypes for animal models of tissue fibrosis and human fibrotic diseases.
- DOI:10.1186/s40169-015-0047-4
- 发表时间:2015
- 期刊:
- 影响因子:10.6
- 作者:Wermuth PJ;Jimenez SA
- 通讯作者:Jimenez SA
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SERGIO A JIMENEZ其他文献
SERGIO A JIMENEZ的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SERGIO A JIMENEZ', 18)}}的其他基金
Serum Exosome MicroRNA in Systemic Sclerosis
系统性硬化症中的血清外泌体 MicroRNA
- 批准号:
9299047 - 财政年份:2017
- 资助金额:
$ 19.88万 - 项目类别:
Role of TRPV channels in the pathogenesis of Systemic Sclerosis vasculopathy
TRPV 通道在系统性硬化症血管病发病机制中的作用
- 批准号:
8702580 - 财政年份:2014
- 资助金额:
$ 19.88万 - 项目类别:
Role of TRPV channels in the pathogenesis of Systemic Sclerosis vasculopathy
TRPV 通道在系统性硬化症血管病发病机制中的作用
- 批准号:
9034722 - 财政年份:2014
- 资助金额:
$ 19.88万 - 项目类别:
Role of TRPV channels in the pathogenesis of Systemic Sclerosis vasculopathy
TRPV 通道在系统性硬化症血管病发病机制中的作用
- 批准号:
8826028 - 财政年份:2014
- 资助金额:
$ 19.88万 - 项目类别:
Role of toll like receptors (TLRs)in Gd contrast agent induced skin fibrosis
Toll样受体(TLRs)在Gd造影剂诱导的皮肤纤维化中的作用
- 批准号:
8301981 - 财政年份:2012
- 资助金额:
$ 19.88万 - 项目类别:
Identification of Novel Markers for Systemic Sclerosis Employing Proteomics
利用蛋白质组学鉴定系统性硬化症的新标记物
- 批准号:
8125088 - 财政年份:2010
- 资助金额:
$ 19.88万 - 项目类别:
Identification of Novel Markers for Systemic Sclerosis Employing Proteomics
利用蛋白质组学鉴定系统性硬化症的新标记物
- 批准号:
7979478 - 财政年份:2010
- 资助金额:
$ 19.88万 - 项目类别:
Role of Caveolin in Scleroderma Tissue Fibrosis and Vasculopathy
Caveolin 在硬皮病组织纤维化和血管病变中的作用
- 批准号:
8078005 - 财政年份:2008
- 资助金额:
$ 19.88万 - 项目类别:
Role of Caveolin in Scleroderma Tissue Fibrosis and Vasculopathy
Caveolin 在硬皮病组织纤维化和血管病变中的作用
- 批准号:
8270386 - 财政年份:2008
- 资助金额:
$ 19.88万 - 项目类别:
Role of Caveolin in Scleroderma Tissue Fibrosis and Vasculopathy
Caveolin 在硬皮病组织纤维化和血管病变中的作用
- 批准号:
7533226 - 财政年份:2008
- 资助金额:
$ 19.88万 - 项目类别:
相似海外基金
The Role of Adenine Nucleotide Translocase in Mitochondrial Dysfunction Associated Senescence in Chronic Obstructive Pulmonary Disease (COPD)
腺嘌呤核苷酸转位酶在慢性阻塞性肺病(COPD)线粒体功能相关衰老中的作用
- 批准号:
10633608 - 财政年份:2023
- 资助金额:
$ 19.88万 - 项目类别:
Pathways of Succinate Accumulation and Adenine Nucleotide Depletion in Cardiac Ischemia
心脏缺血中琥珀酸积累和腺嘌呤核苷酸消耗的途径
- 批准号:
10534031 - 财政年份:2022
- 资助金额:
$ 19.88万 - 项目类别:
Pathways of Succinate Accumulation and Adenine Nucleotide Depletion in Cardiac Ischemia
心脏缺血中琥珀酸积累和腺嘌呤核苷酸消耗的途径
- 批准号:
10794933 - 财政年份:2022
- 资助金额:
$ 19.88万 - 项目类别:
Development of nobel assay methods for miRNA and adenine methyltransferase using FRET
使用 FRET 开发 miRNA 和腺嘌呤甲基转移酶的诺贝尔检测方法
- 批准号:
21K05120 - 财政年份:2021
- 资助金额:
$ 19.88万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Critical assessment of DNA adenine methylation in brain cells from healthy aging and Alzheimer's disease
健康老龄化和阿尔茨海默病脑细胞 DNA 腺嘌呤甲基化的批判性评估
- 批准号:
10365337 - 财政年份:2021
- 资助金额:
$ 19.88万 - 项目类别:
DNA Methylation at N6-Adenine in Placental Trophoblast Development
胎盘滋养层发育中 N6-腺嘌呤 DNA 甲基化
- 批准号:
10033546 - 财政年份:2020
- 资助金额:
$ 19.88万 - 项目类别:
DNA Methylation at N6-Adenine in Placental Trophoblast Development
胎盘滋养层发育中 N6-腺嘌呤 DNA 甲基化
- 批准号:
10613902 - 财政年份:2020
- 资助金额:
$ 19.88万 - 项目类别:
DNA Methylation at N6-Adenine in Placental Trophoblast Development
胎盘滋养层发育中 N6-腺嘌呤 DNA 甲基化
- 批准号:
10226235 - 财政年份:2020
- 资助金额:
$ 19.88万 - 项目类别:
DNA Methylation at N6-Adenine in Placental Trophoblast Development
胎盘滋养层发育中 N6-腺嘌呤 DNA 甲基化
- 批准号:
10396102 - 财政年份:2020
- 资助金额:
$ 19.88万 - 项目类别:
DNA Methylation at N6-Adenine in Placental Trophoblast Development
胎盘滋养层发育中 N6-腺嘌呤 DNA 甲基化
- 批准号:
10705982 - 财政年份:2020
- 资助金额:
$ 19.88万 - 项目类别: